Literature DB >> 823095

Biochemical characterization of the human carbonic anhydrase variant CA Ih Hiroshima.

R J Tanis, W R Osborne, N Ueda, R E Tashian.   

Abstract

Some biochemical properties of a new red cell human carbonic anhydrase variant, CA Ih Hiroshima, have been determined. Evidence is presented that the amino acid substitution in the Japanese variant is not the same as the previously characterized CA Ic variant from Guam of similar electrophoretic mobility. Based on a comparison with the normal CA I isoenzyme, a proposal for the site of the amino acid substitution is presented.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 823095     DOI： 10.1007/BF00284431

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


  13 in total

1.  Inherited variant of erythrocyte carbonic anhydrase in micronesians from Guam and Saipan.

Authors:  R E TASHIAN; C C PLATO; T B SHOWS
Journal:  Science       Date:  1963-04-05       Impact factor: 47.728

2.  Spectroscopic determination of tryptophan and tyrosine in proteins.

Authors:  H Edelhoch
Journal:  Biochemistry       Date:  1967-07       Impact factor: 3.162

3.  Characterization of a mutant human erythrocyte carbonic anhydrase: carbonic anhydrase Ic-Guam. The amino acid substitution and carboxylesterase and hydratase activities.

Authors:  R E Tashian; S K Riggs; Y S Yu
Journal:  Arch Biochem Biophys       Date:  1966-11       Impact factor: 4.013

4.  Red cell carbonic anhydrase Ic in Filipinos.

Authors:  L I Eng
Journal:  Am J Hum Genet       Date:  1967-03       Impact factor: 11.025

5.  Carbonic anhydrase-azosulfonamide complexes. Spectral properties.

Authors:  J E Coleman
Journal:  J Biol Chem       Date:  1968-09-10       Impact factor: 5.157

6.  New Japanese variant of human erythrocyte carbonic anhydrase.

Authors:  N Ueda
Journal:  Jinrui Idengaku Zasshi       Date:  1974-09

7.  Genetic red cell abnormalities in Trengganu and Perlis (West Malaysia).

Authors:  L I Eng; D A McKay; S Govindasamy
Journal:  Southeast Asian J Trop Med Public Health       Date:  1971-06       Impact factor: 0.267

8.  Phosphoglucomutase, carbonic anhydrase and catalase in Indonesians.

Authors:  L E Lie-Injo; H G Poey Oey
Journal:  Hum Hered       Date:  1970       Impact factor: 0.444

9.  The frequency in Japanese of genetic variants of 22 proteins II. Carbonic anhydrase I and II, lactate dehydrogenase, malate dehydrogenase, nucleoside phosphorylase, triose phosphate isomerase, haemoglobin A and haemoglobin A2.

Authors:  N Ueda; C Satoh; R J Tanis; R E Ferrell; S Kishimoto; J V Neel; H B Hamilton; K Baba
Journal:  Ann Hum Genet       Date:  1977-07       Impact factor: 1.670

10.  Thermal inactivation studies of normal and variant human erythrocyte carbonic anhydrases by using a sulphonamide-binding assay.

Authors:  W R Osborne; R E Tashian
Journal:  Biochem J       Date:  1974-07       Impact factor: 3.857
View more
  4 in total

Review 1.  Rare variants, private polymorphisms, and locus heterozygosity in Amerindian populations.

Authors:  J V Neel
Journal:  Am J Hum Genet       Date:  1978-09       Impact factor: 11.025

2.  Chemical characterization of a new Japanese variant of carbonic anhydrase I, CA INagasaki 1 (76 arg leads to gln).

Authors:  K Goriki; R E Tashian; S K Stroup; Y S Yu; D M Henriksson
Journal:  Biochem Genet       Date:  1979-06       Impact factor: 1.890

3.  Amino acid substitution and chemical characterization of a Japanese variant of carbonic anhydrase I: CA I Hiroshima-1 (86 Asp replaced by Gly).

Authors:  T Kageoka; D Hewett-Emmett; S K Stroup; Y S Yu; R E Tashian
Journal:  Biochem Genet       Date:  1981-06       Impact factor: 1.890

4.  A polymorphic variant of human erythrocyte carbonic anhydrase I with a widespread distribution in Australian aborigines, CAI Australia-9 (8 Asp leads to Gly): purification, properties, amino acid substitution, and possible physiological significance of the variant enzyme.

Authors:  G L Jones; D C Shaw
Journal:  Biochem Genet       Date:  1982-10       Impact factor: 1.890
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.